Galligan Joseph J's Form 4 filing
BioCorRx Inc. (BICX) · filed Jul 6, 2023
- Accession no.
- 0001477932-23-005033
- Filed
- Jul 6, 2023
- Trade date
- Sep 30, 2022-Jun 30, 2023
- Filing delay
- 279 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. Open-market purchases total $299.8K. It was filed 279 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Galligan Joseph JCIK 0001198613 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2022 | Common Stock, par value $0.001 | AGrant or awardAcquired | +2,450 | $0.00 | $0 | 40,931 | Direct | |
| Dec 30, 2022 | Common Stock, par value $0.001 | AGrant or awardAcquired | +5,319 | $0.00 | $0 | 46,250 | Direct | |
| Mar 29, 2023 | Common Stock, par value $0.001 | PPurchaseAcquired | +171,296 | $1.75 | +$299,768 | 217,546 | Indirect | |
| Mar 31, 2023 | Common Stock, par value $0.001 | AGrant or awardAcquired | +2,824 | $0.00 | $0 | 220,370 | Direct | |
| Jun 30, 2023 | Common Stock, par value $0.001 | AGrant or awardAcquired | +2,891 | $0.00 | $0 | 223,261 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.